Low serum levels of testosterone in men with minimal traumatic hip fractures

Experimental and Clinical Endocrinology and Diabetes

Volumn 113, Issue 4, 2005, Pages 208-213

  Leifke, Eckhard ^a,c   Wichers, C ^b   Gorenoi, V ^a   Lucke, P ^b   Von Zur Muhlen A ^a   Brabant, C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Geriatric Centre of Hagenhof Hospital   (Germany)

^c BAYER PHARMA AG   (Germany)

Author keywords

(Minimal traumatic) hip fracture; Hypogonadism; Male osteoporosis; Testosterone

Indexed keywords

25 HYDROXYVITAMIN D; ESTRADIOL; PARATHYROID HORMONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

AGED; ARTICLE; BONE DENSITY; BONE MASS; CLINICAL ARTICLE; DATA ANALYSIS; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; LONGITUDINAL STUDY; MALE; MORBIDITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL;

AGED; BONE DENSITY; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ESTRADIOL; HIP FRACTURES; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; REFERENCE VALUES; SPINE; TESTOSTERONE; WOUNDS AND INJURIES;

EID: 18844440665     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-837652     Document Type: Article

References (40)

1. Behre HM, Kliesch S, Leifke E, Link TM, Nieschlag E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. Journal of Clinical Endocrinology and Metabolism 1997; 82: 2386-2390
2. Behre HM, Yeung CH, Holstein AF, Weinbauer GF, Gassner P, Nieschlag E. Diagnosis of male infertility and hypogonadism. In: Nieschlag E, Behre HM (eds). Andrology: Male Reproductive Health and Dysfunction. 2nd ed. New York, Heidelberg, Berlin: Springer Verlag, 2000: 90-140
3. Boonen S, Vanderschhueren D, Cheng XG, Verbeke G, Dequeker J, Geusens P, Broos P, Bouillon R. Age-related (typeII) femoral neck osteoporosis in men: biochemical evidence for both hypovitaminosis D- and androgen deficiency-induced bone resorption. J Bone Mineral Res 1997; 12: 2119-2126
4. Center JR, Nguyen TV, Sambrook PN, Eisman JA. Hormonal and biochemical parameter and osteoporotic fractures in elderly men. J Bone Mineral Res 2000; 15: 1405-1411
5. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ. Vitamin D3 and calcium to prevent hip fractures in elderly women. New Engl J Med 1992; 327: 1637-1642
6. Daniell HW. Narcotic-induced hypogonadism during therapy for heroin addiction. J Addict Disorders 2002; 21: 47-53
7. Diamond T, Smerdely P, Kormas N, Sekel R, Vu T, Day P. Hip fractures in elderly men: the importance of subclinical vitamin D deficiency and hypogonadism. Med J Australia 1998; 169: 138-141
8. Finkelstein JS. Androgens and bone metabolism. In: Nieschlag E, Behre HM (eds). Testosterone Action Deficiency Substitution. 2nd ed. Berlin, Heidelberg, New York: Springer Verlag, 1998: 187-208
9. Jackson JA, Riggs MW, Spiekermann AM. Testosterone deficiency as a risk factor to the occurence for hip fractures in men: a case control study. Am J Med Sci 1992; 304: 4-8
10. Kalender WA, Felsenberg D, Louis O, Lopez P, Klotz E, Osteaux M, Fraga J. Reference values for trabecular and cortical vertebral bone density in single and dual-energy quantitative computed tomography. Eur J Radiol 1989; 9: 75-80
11. Kaufmann JM, Vermeulen A. Androgens and senescence. In: Nieschlag E, Behre HM (eds). Testosterone Action Deficiency Substitution. 2nd ed. Heidelberg, Berlin, New York: Springer Verlag, 1998: 437-472
12. Kenny AM, Prestwood KM, Marcello KM, Raisz LG. Determinants of bone density in healthy older men with low testosterone level. J Gerontol Medical Sciences 2000; 55: M492-M497
13. Kenny AM, Prestwood KM, Gruman CA, Marcello KM, Raisz LG. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol Medical Sciences 2001; 56 A (5): M266-M272
14. Kiebzak GM, Beinart GA, Perser K, Ambrose CG, Siff SJ, Heggeness MH. Undertreatment of osteoporosis in men with hip fracture. Archive Internal Medicine 2002; 162: 2217-2222
15. Khosla S. The effects of androgens on osteoblast function in vitro. Mayo Clinic Proceedings 2000; 75 (Suppl): 51-54
16. Khosla S. Oestrogen, bones and men: when testosterone just isn't enough. Clin Endocrinol (Oxf) 2002; 56: 291-293
17. Leifke E, Korner HC, Link TM, Behre HM, Peters PE, Nieschlag, E. Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men. Eur J Endocrinol 1998; 138: 51-58
18. Leifke E, Gorenoi V, Wichers C, von zur Mühlen A, von Büren E, Brabant G. Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex hormone binding globulin levels in men: cross sectional data from a healthy male cohort. Clin Endocrinol (Oxf) 2000; 53: 689-695
19. Mawer EB, Davies M. Vitamin D nutrition and bone disease in adults. Rev Endocrine Metab Disorders 2001; 4: 153-164
20. Meikle AW. Androgen replacement therapy of male hypogonadism. In: Meikle AW (ed). Contemporary Endocrinology: Hormone Replacement Therapy. Totowa NJ: Humana Press Inc, 1999: 263-306
21. Mussolino ME, Looker AC, Madans JH, Langlois JA, Orwoll ES. Risk factors for hip fracture in white men: the NHANES I Epidemiologic Follow-up Study. J Bone Mineral Res 1998; 13: 918-924
22. Nyquist F, Gardsell P, Sernbo I, Jeppsson JO, Jonell O. Assessment of sex hormones and bone mineral density in relation to occurence of fracture in men: a prospective population based study. Bone 1998; 22: 147-151
23. Ohishi T, Takahashi M, Kushida K, Omura T. Biochemical markers and bone mineral density in patients with hip fractures in men. Endocrine Research 2000; 26: 275-288
24. Poor G, Atkinson EJ, O'Fallon WM, Melton J. Determinants of reduced survival following hip fractures in men. Clin Orthop related Res 1995; 319: 260-265
25. Orwoll ES and Klein RF. Osteoporosis in men. Endocrine Rev 1995; 16: 87-144
26. Orwoll ES. Androgens: basic biology and clinical implication. Calcified Tissue International 2001; 69: 185-188
27. Orwoll ES, Stribrska L, Ramsey EE, Keenan EJ. Androgen receptors in osteoblast-like cell lines. Calcified Tissue International 1991; 49: 183-187
28. Pfeifer M, Begerow B, Minne HW, Jensen SB, Christiansen C. Effect of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Mineral Res 2000; 15: 1113-1118
29. Quesada JM, Coopmans W, Ruiz B, Aljama P, Jans I, Bouillon R. Influence of vitamin D on parathyroid function in elderly. J Clin Endocrinol Metab 1992; 75: 494-501
30. Seeman E. Unresolved issues in osteoporosis in men. Rev Endocrine Metab Disorders 2001; 2: 45-64
31. Seeman E. The dilemma of osteoporosis in men. Am J Med 1995; 98: 76-88
32. Shozu M and Simpson ER. Aromatase expression of human osteoblast-like cells. Mol Cell Endocrinol 1998; 139: 117-129
33. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Holmes JH, Dlewati A, Staley J, Santanna J, Kapoor SC, Attie MF, Haddad JG Jr, Strom BL. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 1999; 84: 1966-1972
34. Stanley HL, Schmitt BP, Poses RM, Deiss WP. Does hypogonadism contribute to the occurence of minimal trauma hip fracture in elderly men? J Am Geriatrics Society 1991; 39: 766-771
35. Trombetti A, Hermman F, Hoffmeyer P, Schurch MA, Bonzour JP, Rizzoli R. Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporosis Int 2002; 13: 731-737
36. Van den Berghe G. Dynamic neuroendocrine responses to critical illness. Front Neuroendocrinology 2002; 23: 370-391
37. Wang C, Chan V, Yeung RTT. 1978. Effect of surgical stress on pituitary-testicular function. Clin Endocrinol (Oxf) 1978; 9: 249-253
38. Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunnigham G, Matsumoto AM, Weber T, Berman N, and the Testosterone Gel Study Group. Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men. Clin Endocrinol (Oxf) 2001; 54: 739-750
39. Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Berman N, Hull L, Swerdloff R. Long-term testosterone gel (Androgel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 2004; 89: 2085-2098
40. Zitzmann M, Brune M, Kornmann B, Gromoll J, Junker R, Nieschlag E. The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males. Clin Endocrinol (Oxf) 2001; 55: 649-657